Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

DexCom plans to launch its 15-day G7 sensor in the second half of 2025, pending FDA approval. A longer wear time may boost ...

By seamlessly integrating Dexcom CGM data with NovoPen® 6 and NovoPen Echo® Plus insulin data in one app, healthcare professionals gain a comprehensive, actionable view of a patient’s glucose ...